바이오해저드 백 시장 : 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the biohazard bags market size was valued at USD 436.41 million in 2025 and estimated to grow from USD 472.37 million in 2026 to reach USD 701.32 million by 2031, at a CAGR of 8.24% during the forecast period (2026-2031).

This report is Segmented by Product Material (LDPE, HDPE, Polypropylene, and More), Application (Infectious Waste, Healthcare (General Medical) Waste, and More), End User (Hospitals, Diagnostic Laboratories, and More), Geography (North America, Europe, Asia-Pacific, The Middle East and Africa, and South America). The Market Forecasts are Provided in Terms of Value (USD).

Global Biohazard Bags Market Trends and Insights

Accelerating Generation of Biomedical Waste

Healthcare facilities now classify 15% of waste as hazardous, a share that remains elevated after 2020. Intensive care units and emergency departments generate larger volumes of contaminated disposables than before, and the World Health Organization's guidance on point-of-generation segregation has become a routine benchmark. Hospitals respond by purchasing colour-coded bag systems that align with federal, state and international requirements for traceability, puncture resistance and leak protection. Mandatory staff-training modules on handling procedures further increase reorder frequency, making this factor one of the most durable growth contributors for the biohazard bags market.

Expansion of Global Healthcare Infrastructure

Asia-Pacific governments are commissioning hospitals, outpatient clinics and diagnostic hubs at a pace unmatched elsewhere. These projects embed medical-waste rooms, automated bag-sealers and inspection points into facility blueprints. New plants for biologics and vaccines use containment specifications based on United States and European Union rules, which accelerates demand for thicker-gauge polypropylene and high-density polyethylene bags. Builders and operators also stipulate eco-labels as they move toward sustainable procurement targets set by regional authorities. The long-term investment cycle therefore feeds continuous volume growth across the biohazard bags market.

Availability of Reusable Waste Containment Systems

Large hospitals adopting circular-economy objectives trial bag-less cart systems that integrate solid plastic linings and sealed lids. Firms such as Daniels Health market cassette-style sharps units that can be emptied, sterilized and redeployed. Sustainability committees note lower cradle-to-grave emissions and reduced worker-injury risk compared with double-bag techniques. Initial capital outlay and comprehensive staff retraining limit adoption to major networks, yet the option introduces price sensitivity within the biohazard bags market, particularly for low-value red bags.

Other drivers and restraints analyzed in the detailed report include:

1. Stricter Regulatory Compliance for Hazardous Waste Segregation
2. Rising Adoption of Single-Use Medical Consumables
3. Volatility in Polyethylene Raw Material Prices

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Low-density polyethylene commanded 42.11% of the biohazard bags market share in 2025, reflecting its proven flexibility and puncture-resistance attributes that satisfy general infectious-waste handling requirements. The material dominates high-throughput hospital settings where cost, availability and automated-sealing compatibility matter most. However, polypropylene continues to outpace all other resins, and the biohazard bags market size for the polypropylene segment is projected to expand at 10.01% CAGR between 2026 and 2031 thanks to its higher chemical-resistance threshold, suitability for chemotherapeutic and pharmaceutical waste and ability to withstand high-temperature autoclave cycles.

The preference landscape is evolving. Specialized cancer centers and biologics plants often specify high-density polyethylene or multilayer co-extruded structures to secure extra leak resistance. A niche group of facilities is also piloting biopolymers derived from polylactic acid or polyhydroxyalkanoate, aiming to lower carbon footprints, yet uptake remains embryonic because healthcare regulators require exhaustive validation before approving bag materials for hazardous waste. Manufacturers are therefore balancing environmental claims with mandatory ASTM and ISO puncture, tear and transmissibility testing, ensuring that innovation continues without undermining the core performance expectations of the biohazard bags market.

Complete Report Scope:

• By Product Material
  • LDPE
  • HDPE
  • Polypropylene
  • Cellophane
  • Other Product Materials
• By Application
  • Infectious Waste
  • Healthcare (General Medical) Waste
  • Chemical & Pharmaceutical Waste
  • Other Applications
• By End User
  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical & Biologics Manufacturing
  • Other End Users
• Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America retained leadership with a 38.12% revenue share in 2025, anchored by a well-established regulatory network comprising the EPA, OSHA and FDA. Hospitals allocate dedicated compliance budgets to ensure waste-tracking accuracy and purchase bags meeting ASTM D1709 puncture standards. States' uptake of the Hazardous Waste Generator Improvements Rule harmonizes documentation requirements, further embedding standardized liner use and sustaining demand across the United States and Canada. While growth is slower than in developing regions, replacement cycles, red-bag subsidies for rural clinics and consolidation among waste-management service providers preserve market vibrancy.

Asia-Pacific contributes the most dynamic growth storyline. Government funding for new inpatient beds, oncology centers, dialysis units and vaccine plants is accompanied by mandatory waste-segregation guidelines modeled on United States and European Union directives. As governments implement these rules, procurement teams specify minimum bag thickness, bag color by waste class and traceability features. Local manufacturers ramp production, yet premium imports still dominate high-spec orders, ensuring cross-border supply chains form an integral part of the biohazard bags market. With healthcare expenditure rising alongside urban population growth, Asia-Pacific's 9.34% CAGR is likely to remain intact this decade.

Europe maintains a significant market position thanks to Green Deal policy incentives and stringent circular-economy objectives. Hospitals are piloting low-carbon or reusable waste systems, yet infection-prevention priorities keep single-use liners firmly in place for high-risk waste streams. Regulatory authorities such as the European Chemicals Agency frequently update guidance on halogenated plastics, prompting manufacturers to adjust formulations. The Middle East and Africa display moderate yet accelerating growth as Gulf states commission teaching hospitals with Western-style waste rooms, while South America records steady improvement as public-sector hospitals upgrade to meet revised waste-handling laws.

1. Thermo Fisher Scientific
2. SP Bel-Art
3. International Plastics Inc.
4. Inteplast Group (Minigrip)
5. Merck KGaA (MilliporeSigma)
6. Transcendia Inc.
7. Champion Plastics
8. Desco Medical
9. Welpack Industries Pvt. Ltd
10. Propper Manufacturing Co.
11. Daniels Health
12. Stericycle Inc.
13. Lithey Inc.
14. BioMedical Waste Solutions LLC
15. Dana Poly Inc.
16. Plasti-Med (Turkey)
17. PacMed Labs
18. Safetec of America
19. Jiangsu Huanxin High-Tech Materials Co.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Accelerating Generation Of Biomedical Waste
  • 4.2.2 Expansion Of Global Healthcare Infrastructure
  • 4.2.3 Stricter Regulatory Compliance For Hazardous Waste Segregation
  • 4.2.4 Rising Adoption Of Single-Use Medical Consumables
  • 4.2.5 Growth Of Pharmaceutical And Biologics Manufacturing
  • 4.2.6 Increasing Public Health Awareness Of Infection Control
• 4.3 Market Restraints
  • 4.3.1 Availability Of Reusable Waste Containment Systems
  • 4.3.2 Volatility In Polyethylene Raw Material Prices
  • 4.3.3 Emerging Bans On Single-Use Plastics
  • 4.3.4 High Capital Requirements For Waste Treatment Compliance
• 4.4 Regulatory Landscape
• 4.5 Porter's Five Forces Analysis
  • 4.5.1 Threat of New Entrants
  • 4.5.2 Bargaining Power of Buyers
  • 4.5.3 Bargaining Power of Suppliers
  • 4.5.4 Threat of Substitutes
  • 4.5.5 Intensity of Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Product Material
  • 5.1.1 LDPE
  • 5.1.2 HDPE
  • 5.1.3 Polypropylene
  • 5.1.4 Cellophane
  • 5.1.5 Other Product Materials
• 5.2 By Application
  • 5.2.1 Infectious Waste
  • 5.2.2 Healthcare (General Medical) Waste
  • 5.2.3 Chemical & Pharmaceutical Waste
  • 5.2.4 Other Applications
• 5.3 By End User
  • 5.3.1 Hospitals
  • 5.3.2 Diagnostic Laboratories
  • 5.3.3 Pharmaceutical & Biologics Manufacturing
  • 5.3.4 Other End Users
• 5.4 Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
  • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
  • 5.4.4 Middle East & Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East & Africa
  • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and analysis of Recent Developments)
  • 6.3.1 Thermo Fisher Scientific
  • 6.3.2 SP Bel-Art
  • 6.3.3 International Plastics Inc.
  • 6.3.4 Inteplast Group (Minigrip)
  • 6.3.5 Merck KGaA (MilliporeSigma)
  • 6.3.6 Transcendia Inc.
  • 6.3.7 Champion Plastics
  • 6.3.8 Desco Medical India
  • 6.3.9 Welpack Industries Pvt. Ltd
  • 6.3.10 Propper Manufacturing Co.
  • 6.3.11 Daniels Health
  • 6.3.12 Stericycle Inc.
  • 6.3.13 Lithey Inc.
  • 6.3.14 BioMedical Waste Solutions LLC
  • 6.3.15 Dana Poly Inc.
  • 6.3.16 Plasti-Med (Turkey)
  • 6.3.17 PacMed Labs
  • 6.3.18 Safetec of America
  • 6.3.19 Jiangsu Huanxin High-Tech Materials Co.

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment